Chronic allograft injury: Mechanisms and potential treatment targets

Leonardo V Riella1, Arjang Djamali2, Julio Pascual3

  • 1Renal Division, Brigham & Women's Hospital, Harvard Medical School, Boston, MA.

Insights

Kidney graft survival beyond 10 years is challenging. This review highlights non-compliance, antibody-mediated injury, disease recurrence, and BK nephropathy as key factors, shifting focus from calcineurin inhibitors.

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Immunosuppression Management

Background:

  • Long-term kidney graft survival remains a significant challenge in transplantation.
  • A substantial percentage of kidney grafts are lost within 10 years post-transplant.
  • Identifying causes of chronic allograft injury is crucial for improving patient outcomes.

Purpose of the Study:

  • To review recent data on causes of long-term kidney graft injury.
  • To evaluate the declining role of calcineurin inhibitors as the primary cause of injury.
  • To highlight emerging critical factors impacting graft survival.

Main Methods:

  • Literature review of recent studies on kidney transplantation outcomes.
  • Analysis of data regarding causes of chronic allograft injury.
  • Synthesis of information on immunosuppression and non-compliance impacts.

Main Results:

  • Evidence suggests calcineurin inhibitors are less frequently the primary cause of long-term graft injury.
  • Non-compliance, antibody-mediated injury, disease recurrence, and BK nephropathy are increasingly recognized as major culprits.
  • Shifting focus to these factors is essential for therapeutic intervention.

Conclusions:

  • Management strategies for kidney transplant recipients need re-evaluation.
  • Addressing non-compliance, antibody-mediated injury, recurrence, and BK nephropathy may improve long-term graft survival.
  • Optimizing post-transplant care is key to enhancing graft longevity.